Leading infectious diseases clinical research unit in South Africa

At the heart of South Africa's HIV and TB crises, CHRU pioneers clinical research in infectious diseases like HIV, TB, HPV, Hepatitis B/C, and COVID-19. Dedicated scientists at CHRU strive to enhance treatments and improve the lives of affected communities.

World class laboratory at the Clinical HIV Research Unit
Pill count in the The Isango Lethemba TB Research Unit pharmacy

The Clinical HIV Research Unit

South Africa is at the epicentre of the HIV and Tuberculosis (TB) epidemics. The Clinical HIV Research Unit (CHRU) undertakes clinical research to prevent and treat infectious diseases such as HIV, HIV-associated diseases, Tuberculosis (TB), HPV and Hepatitis B and C, and COVID-19. At CHRU, dedicated scientists and clinicians test the safety and efficacy of treatments, understand viruses, and improve the lives of those affected.

Our mission to deliver excellence and quality in clinical research is evident by our impact on the global standard of care. CHRU has forged new paths in the treatment of HIV, TB, and COVID-19.

At the Clinical HIV Research Unit, our journey is more than research—it is a commitment to saving lives and shaping a healthier future for all. Together, we are turning the tide against global health crises, one breakthrough at a time.

Breakthrough research

CHRU is an internationally recognised multi-disciplinary clinical trial unit involved with breakthrough research that contributes to South African and global scientific agendas and public health priorities.

Gowning up for contamination control

Stay informed

Keep up to date with the latest updates and breakthroughs in scientific research in the world of HIV, TB, HPV and Hepatitis B and C, and COVID-19.